Home › Neurofibrosarcoma › Tennessee
Neurofibrosarcoma clinical trials in Tennessee
4 studies for Neurofibrosarcoma are looking for participants at sites in Tennessee.
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
- Sarah Cannon Tennessee Oncology, Nashville
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT05732831Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
- Vanderbilt - Ingram Cancer Center, Nashville
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT05245500NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
- St. Jude Children's Research Hospital, Memphis
RecruitingPhase 1/2
Up to age 30 · All sexes · Updated Aug 3, 2026 · NCT06239272B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
- St. Jude Children's Research Hospital, Memphis
RecruitingPhase 1
Up to age 21 · All sexes · Updated May 19, 2026 · NCT04897321From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.